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Emerging evidence demonstrates that megakaryocytes (MK) play a key role in 
regulating skeletal homeostasis and hematopoiesis. Recent reports show that MK reside in 
close proximity to hematopoietic stem cells (HSC). Genetic depletion of MK resulted in mitotic 
activation of HSC suggesting that MK maintain HSC quiescence. Other studies demonstrated 
that following irradiation, surviving MK migrate to endosteal surfaces where osteoblast (OB) 
lineage cells dramatically increase and promote engraftment of transplanted HSC.  
Here we investigated if MK directly impact hematopoiesis or whether they indirectly 
support HSC function through their interaction with OB-lineage cells. Our data suggests that 
LSK (Lin-Sca+CD117+, an enriched HSC population) co-cultured with MK and OB generate 
significantly higher numbers of colony forming cells (HSC function) compared to LSK co-
cultured with either MK or OB alone. The functionality of this in vitro data was confirmed in vivo 
with transplantation studies which showed increased engraftment in mice transplanted with LSK 
cells co-cultured with OB and MK compared to LSK cells co-cultured with OB alone. To test if 
loss of MK negatively impacts osteoblastogenesis, we generated conditional knockout mice 
where cMpl, the receptor for the main MK growth factor, thrombopoietin (TPO), was deleted in 
MK (cMplfl/fl x PF4Cre). Unexpectedly, these mice exhibited a 10-fold increase in platelet 
numbers, megakaryocytosis, a dramatic expansion of phenotypically defined hematopoietic 
precursors, and a remarkable 20-fold increase in the bone volume fraction. 
Collectively, these data indicate that while MK modulate HSC function, this activity is in 
part mediated through interactions with OB and suggest a complex role for TPO and MK in HSC 
regulation. While work is needed to further elucidate mechanisms, understanding the 
coordinated interaction between MK, OB, HSC, and TPO/Mpl should inform the development of 
novel treatments to enhance HSC recovery following myelosuppressive injuries, as well as bone 
loss diseases, such as osteoporosis.   
 
